Inicio>>Analytical Standards>> Reference Materials>>N-Desmethylclobazam

N-Desmethylclobazam (Synonyms: nor-Clobazam)

Catalog No.GC18744

N-Desmetilclobazam es un material de referencia analítico que se clasifica estructuralmente como una benzodiazepina.

Products are for research use only. Not for human use. We do not sell to patients.

N-Desmethylclobazam Chemical Structure

Cas No.: 22316-55-8

Tamaño Precio Disponibilidad Cantidad
100µg
162,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
N-Desmethylclobazam is an analytical reference material that is structurally categorized as a benzodiazepine. It is a major active metabolite of clobazam, produced primarily by the action of cytochrome P450 isoform 3A4. N-Desmethylclobazam positively modulates GABAA receptors (EC50s range from 98 to 151 uM, depending on subunit configuration). This product is intended for research and forensic applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

Reseñas

Review for N-Desmethylclobazam

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-Desmethylclobazam

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.